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Background: Subjective tinnitus is a phantom sensation experienced in the absence of any source of sound. Its
mechanism remains unclear, and no approved drugs are available. Vagus nerve stimulation (VNS) is an exciting
new method to treat tinnitus, but direct electrical stimulation of the cervical vagus has disadvantages. This
randomized controlled clinical trial aims to overcome these limitations by stimulating the auricular branch of
vagus nerve (ABVN) on the outer ear. Since the ABVN is the only peripheral branch of the vagus nerve distributed
on the ear’s surface, it should be possible to achieve analogous efficacy to VNS by activating the central vagal
pathways. However, researches have indicated that the curative effect lies in a combination of auditory and vagal
nerve stimulation. Moreover, from traditional Chinese theory, auricular acupoints used to treat tinnitus are mainly
in the regions supplied by the ABVN. Whether stimulation at the auricular acupoints is due to unintentional
stimulation of vagal afferent fibers also needs evidence.
Methods/design: A total of 120 subjects with subjective tinnitus are randomized equally into four groups: (1)
electrical stimulation at auricular acupoints (CO10, CO11, CO12, and TF4) innervated by the ABVN; (2) electrical
stimulation at auricular acupoints (CO10, CO11, CO12, and TF4) innervated by ABVN pairing tones; (3) electrical
stimulation at auricular acupoints innervated by non-ABVN pairing tones; (4) electrical acupuncture. Patients will
be treated for 30 minutes every other day for 8 weeks. The primary outcome measure is the Tinnitus Handicap
Inventory. The secondary outcome measure combines a visual analogue scale to measure tinnitus disturbance
and loudness with the Hospital Anxiety and Depression Scale. Assessment is planned at baseline (before treatment)
and in the 4th and 8th week, with further follow-up visits after termination of the treatment at the 12th week. Any
adverse events will be promptly documented.
Discussion: Completion of this trial will help to confirm whether ABVN or the combination of ABVN and sound
stimulus plays a more important role in treating tinnitus. Moreover, the result of this clinical trial will enhance our
understanding of specific auricular acupoints.
Trial registration: Chinese Clinical Trials Register ChiCTR-TRC-14004940.
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Subjective tinnitus is considered as a phantom sensation
experienced in the absence of any internal or external
acoustic stimulus. It can be perceived as a hissing, buzz-
ing, humming, roaring, whistling, or ringing sound in
one or both ears, or somewhere in the head. At present,
tinnitus has becoming the most common otology prob-
lem, affecting 10% to 30% of the general population and
an estimated prevalence of 24.2% in the older population
[1]. Meanwhile, with the growing popularity of electronic
music, young people experience transient or permanent
tinnitus at a ratio of 89.5% and 14.8%, respectively, after ex-
posure to loud music [2]. Among severe tinnitus sufferers,
tinnitus-related sensations, such as anxiety, annoyance,
frustration, and depression lead to a negative impact on
quality of life in 70% of those affected [3], and they are usu-
ally told that they must learn to live with it. Yet the patho-
logical mechanisms that underlie tinnitus perception
remain largely hypothetical and are still not well under-
stood. Currently, the universally accepted hypothesis is that
interactions between altered cochlear inputs and distorted
central auditory processing provoke tinnitus. Studies have
supported that subjective tinnitus may be a result of the
expression of neural plasticity and that anomalies may
develop because of decreased input from the ear,
deprivation and sound stimulation, overstimulation or
other factors as yet unknown. For the buried patho-
logical mechanisms, treatment options are limited. No
physiotherapy treatments can yet be considered suffi-
cient in providing long-term reduction of tinnitus im-
pact and there is no drug approved by the European
Medicines Agency or the Food and Drug Administra-
tion on the market [4,5]. Therefore, an effective and
safe therapy for tinnitus is of considerable importance
to meet this significant unmet clinical need.
Vagus nerve stimulation (VNS) is approved by the
Food and Drug Administration for both refractory epi-
lepsy and resistant depression [6,7]. VNS offers an excit-
ing new perspective for the treatment of tinnitus and it
has recently been demonstrated that VNS is a promising
method [8]. In this method, an electrode surgically im-
planted around the left cervical vagus nerve is connected
to a pulse generator placed subcutaneously in the upper
chest. However, considering the disadvantages of the im-
plantation, including lesions of the vagus nerve, infec-
tion, shortness of breath, possible mechanical failure of
electronic equipment, and battery replacement, a rela-
tively safe and well tolerated improved method is
desired. To minimize side effects, stimulation of the aur-
icular branch of vagus nerve (ABVN) has been suggested
[9]. The ABVN is the only peripheral branch of the
vagus nerve distributed on the surface of ear, and studies
using the transganglionic horseradish peroxidase method
[10,11] have shown that it mainly projects to the nucleusof the solitary tract in the brainstem. Functional magnetic
resonance imaging and vagus sensory evoked potentials re-
vealed that ABVN stimulation shows considerable similarity
to implanted VNS, with both acting through the central
auditory pathway of the vagus nerve [12,13]. Thus, it would
be safer simply to deliver mild electric shocks to the skin of
the outer ear instead of resorting to VNS with surgery.
However, some researchers reported that ABVN stimula-
tion alone seems to have no relevant improvement of
tinnitus complaints [8,14], and it is suggested that the com-
bination with other interventions, such as sound stimuli,
which would reduce the cortical response to mid-frequency
tones, increase frequency selectivity, and decrease cortical
synchronization [15] should be considered. But there is not
currently enough evidence in clinical practice of the effect
of the method of pairing tones with stimulation at ABVN.
Moreover, auricular acupuncture, the underlying
mechanism of which is unclear, has been used to treat
tinnitus for thousands of years [16]. Auricular acu-
points applied to treat tinnitus such as Kidney (CO10),
Yidan (CO11), Liver (CO12) and Shenmen (TF4) are
distributed in the regions supplied by ABVN [17]. So
whether auricular acupoints are due to an unintentional
stimulation of the vagal afferent fibers also needs more
clinical and experimental evidence.
Therefore, we have designed a randomized, four-arm,
controlled clinical study to provide a conclusive answer.
In this trial, our aim is to attempt to confirm whether
ABVN or the combination of ABVN and sound stimulus
plays a more important role in the treatment of tinnitus.
Moreover, the result of this clinical trial will enhance
our understanding of specific auricular acupoints.
Methods/design
Design
This is a randomized, single-blind, four-armed, controlled
clinical trial conducted in Yichang Hospital of Traditional
Chinese Medicine, Clinical Medical College of Traditional
Chinese Medicine, China Three Gorges University. Study
patients will be screened based on specific inclusion and
exclusion criteria. Before beginning the treatment, all candi-
dates will undergo a standard neuro-otological examination
and a baseline audiometric assessment, including
measurement of hearing thresholds, minimal masking
levels, loudness discomfort levels, and stapedial re-
flexes, performed by professional audiologists. Then
they will be equally randomized into four groups: (1)
electrical stimulation at auricular acupoints (CO10,
CO11, CO12, and TF4) innervated by ABVN (the
ABVN group); (2) electrical stimulation at auricular
acupoints (CO10, CO11, CO12, and TF4) innervated
by ABVN pairing tones (the ABVN plus tone group);
(3) electrical stimulation at auricular acupoints inner-
vated by non-ABVN pairing tones (the non-ABVN
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Detailed information regarding the clinical procedures
is presented in Figure 1. The clinical endpoints are
assessed by blinded independent statisticians. Any
adverse effects during the course will be reported.
This trial was registered on the Chinese Clinical Trial
Register (ChiCTR-TRC-14004940).
The trial will be performed according to the princi-
ples of the Declaration of Helsinki (Edinburgh version,
2000). In addition, written informed consent will be
obtained from all participants. Ethical permission was
obtained from the Research Ethical Committee of
Yichang Hospital of Traditional Chinese Medicine,
Clinical Medical College of Traditional Chinese Medicine,
China Three Gorges University. The ethics committee ap-
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Figure 1 Flow chart. ABVN, auricular branch of vagus nerve; HADS, Hospit
VAS, visual analogue scale.Recruitment period and methods
Patients will be enrolled in Yichang Hospital of Traditional
Chinese Medicine, Clinical Medical College of Traditional
Chinese Medicine, China Three Gorges University with a
target sample size of 120 subjects. We will recruit the par-
ticipants by advertising in the hospitals, in public newspa-
pers and on the internet homepages of hospitals. The trial
will be executed from July 2014 to July 2015.
Types of participant
Inclusion criteria
Qualified participants meeting all of the following condi-
tions will be recruited [18,19]:
1. Single-tone subjective tinnitus, typical conditions of
unilateral or bilateral;ctive tinnitus
ligibility
Exclude:
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al Anxiety and Depression Scale; THI, Tinnitus Handicap Inventory;
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3. Recurrent attacks for more than 1 month or persist
attacks for more than 5 days;
4. Must be able to hear stimulation tones presented by
the device at all frequencies;
5. Must be able to complete the forms and use the
rating scales;
6. Not be taking part in any other clinical trial during
the period;
7. Voluntarily signed informed consent forms.
Exclusion criteria
Participants who experience or have one or more of the
following conditions will be excluded:
1. Objective tinnitus or Ménière’s disease;
2. Tinnitus induced by otitis media, otitis interna or
cerebellopontine angle tumors;
3. Postcochlear lesion;
4. Patients with severe diabetes, hypertension or
cardiovascular disease, or mental disease;
5. Patients unable to read, understand and complete
the forms or use the rating scales;
6. Pregnant or preparing for pregnancy.
Randomization and blinding
One researcher screens and enrolls participants at the
clinic. Patients are numbered according to registration
order. After participants have completed a baseline evalu-
ation, another researcher who is uninvolved with data col-
lection randomly assigns them to one of four treatment
groups in a 1:1:1:1 ratio using a computer-generated,
blocked randomization sequence generated using SPSS
15.0 software (SPSS Inc., Chicago, IL, USA). This researcher
informs the therapist of the treatment assignment.
We applied a single-blind design in which the study pa-
tients, data collocation staff, and data analysts are blinded
during the study protocol. The therapists are not blinded to
the treatments they deliver because treatment manipulation
makes it impossible. During the intervention, therapists
and data collection staff are instructed not to exchange in-
formation with each other nor communicate with the study
patients.
Interventions
Specific interventions of each group are as follows
(Figure 2).
ABVN group
All participants will receive transcutaneous electrical
stimulation at auricular acupoints innervated by the
ABVN. The points are located at the cymba conchae
and the triangular fossa, where there is rich ABVNdistribution [17]. Main stimulation points according to
standard practice include Kidney (CO10), Yidan (CO11),
Liver (CO12), and Shenmen (TF4). A transcutaneous
electrical nerve stimulator (Suzhou Medical Appliance
Co. Ltd., Suzhou, China) will be used in this group. Two
carbon-impregnated silicone electrode tips are con-
nected to the transcutaneous electrical nerve stimulator
by metal wire; one tip contacts the skin surface points
and the other acts as a terminal end in the ear. The
stimulation frequency is 20 Hz, the stimulation current
is 1 to 5 mA, with stimulus pulses shorter than 1 ms in
duration. Each session will last 30 minutes; sessions are
performed every other day for 8 weeks.
ABVN plus tone group
The format will be exactly the same as for the ABVN
group. Multiple tones will be delivered by Tinnitus
Measurer software (Neonix, USA) at a comfortable lis-
tening level during the transcutaneous electrical nerve
stimulation. Randomly interleaved pure tones that span
the hearing range but exclude the tinnitus tone will be
selected. Each session will last 30 minutes; sessions are
performed every other day for 8 weeks.
Non-ABVN plus tone group
The format of this group will be the same as for the
ABVN plus tone group, except that the subjects receiv-
ing stimulation will be stimulated at auricular acupoints
supplied by the great auricular nerve [17]. Each session
will last 30 minutes; sessions are performed every other
day for 8 weeks.
Electrical acupuncture group
The subjects of this group will be treated with electrical
acupuncture at local and distal points. Acupuncture points
are selected as follows. 1. local acupoints: Yifeng (TE17),
Tinghui (GB2); 2. distal acupoints: Xiaxi (GB43), Zhongzhu
(TE3). Patients will be in a comfortable and relaxed pos-
ition and asked to concentrate on the treatment task. After
the needles are inserted into the acupoints, they will
be connected to an electrical point stimulation device
(G6805-2A, Shanghai Huayi Medical Instrument CO., Ltd,
Shanghai, China) operating at a frequency of 20 Hz and
current of 1 to 5 mA, with pulses shorter than 1 ms in dur-
ation. The intensity will be adjusted individually based on
the tolerance of the patient. All parameters of the electrical
stimulation inducing twitching of the muscles indicate ef-
fective stimulus. After retaining the needles for 30 min, all
needles are taken out using alcohol-soaked cotton balls to
avoid infection and bleeding.
The needles (Suzhou Medical Supplies Factory Co.,
Ltd. Suzhou, China) used in this group are 25 mm in
length and 0.3 mm in diameter. Electrical acupuncture is
performed by a therapist with rich clinical experience
Figure 2 Locations and stimulation devices. (A) Points used in the ABVN group and the ABVN plus tone group for transcutaneous electrical
nerve stimulation. (B) Points used in the non-ABVN plus tone group for transcutaneous electrical nerve stimulation. (C) Acupoints used in the
electrical acupuncture group. (D) Locations of acupoints in the acupuncture group. local acupoints: Tinghui (GB2) and Yifeng (TF17); distal
acupoints: Zhongzhu (TE3) and Xiaxi (GB43). (E) Innervation of the human auricle, including ABVN (blue grid), great auricular nerve (green grid)
and auriculotemporal nerve (red grid) [17]; the black areas show the specific auricular acupoints. TF4, CO10-12, and HX1 are used in the ABVN
group and the ABVN plus tone group; HX9 and LO5 are used in the non-ABVN plus tone group. (F) Ideograph of sound (tones) stimulus: each
speakers is equidistant from the head of the subject.
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tioners from the Ministry of Health of China. Treatment
will be conducted over a period of 8 weeks, at a fre-
quency of every other day.
Primary outcome measures
The primary outcome is evaluated using the Tinnitus
Handicap Inventory, which evaluates 25 items grouped
into a functional subscale (11 factors), an emotional sub-
scale (9 factors), and a catastrophic subscale (5 factors).
Each question of the Tinnitus Handicap Inventory can
be answered by either ‘often’ (4 points), ‘sometimes’ (2
points), or ‘never’ (0 points). The total score allows the
tinnitus to be categorized as: ‘slight’ (0 to 16 points),
‘mild’ (18 to 36 points), ‘moderate’ (38 to 56 points), ‘severe’(58 to 76 points), or ‘catastrophic’ (78 to 100 points). The
assessment is at baseline (before randomization), and in the
4th and 8th week, with further follow-up visits after termin-
ation of the treatment at the 12th week.
Secondary outcome measures
A visual analogue scale, measuring the disturbance and
the loudness of the tinnitus will be used. This consists of
100 mm lines with ‘0 = total absence’ and ‘100 =max-
imum’ of tinnitus disturbance and loudness, respectively.
The severity of both anxiety and depression is evalu-
ated using the Hospital Anxiety and Depression Scale, in
which seven items for anxiety and another seven items
for depression are assessed. Each item is answered by
the patients on a four point (0 to 3) response category.
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as being in the normal range, a score of 8 to 10 is just
suggestive of the presence of the respective state and a
score of 11 or higher indicates the probable presence of
the mood disorder [20]. Both of these assessments will
be used at baseline (before randomization), and in the
4th and 8th week, with further follow-up visits after ter-
mination of the treatment at the 12th week.
Statistical methods
The trial aims to detect a difference between the four
study groups. We present here our power analysis for
the primary outcome only. This is deemed a clinically
significant difference of a 20-point or greater reduction
in score on the Tinnitus Handicap Inventory following
treatments. Since this is a novel therapy, we used data
from a previous proof-of-concept feasibility study [21],
the mean decrease rate is 28% in the VNS group and
0.97% in the control group.
The following formula was used for a four-group
trial [22]:





Calculations are performed using 80% power and a 5%
significance level (two-side). The required sample size is
approximately 27 participants for each group. Assuming
a 10% dropout rate, we plan to enroll a total of 120 par-
ticipants with four groups of equal size (30 participants
per group).
Statistical analysis
In this trial, our primary outcome measure is the
Tinnitus Handicap Inventory. We define the treatment
response as a reduction in score on the Tinnitus Handi-
cap Inventory following treatments of 20 points or more.
First, baseline characteristics will be analyzed using
descriptive statistics for each group. Then repeated mea-
sures analysis is performed to make comparisons among
the treatment groups and the control group (ABVN plus
tone versus electrical acupuncture, non-ABVN plus tone
versus electrical acupuncture, and ABVN versus elec-
trical acupuncture) at different time points (4th, 8th, and
12th week). If a significant difference is found, the next
step is to make comparisons among the three treatment
groups in effectiveness. Multiple comparisons will be ad-
justed according to the Bonferroni correction method.
The Kruskal-Wallis test will be employed in the analysis
of skewed distribution data. Analysis of variance will be
used for numerical variables, and the χ2 test for categor-
ical variables.Statistical analysis will be performed by the Medical
College of China Three Gorges University, No.8, University
Avenue, Yichang, Hubei, China. The statistician is blinded
from the allocation of groups. The SPSS 15.0 software
package (SPSS Inc., Chicago, IL, USA) will be used to
analyze the data.
Participant protections and ethics
The protocol adheres to the latest revision of the
Helsinki Declaration and the Chinese law of human
study and has been approved by the Research Ethical
Committee of Yichang Hospital of Traditional Chinese
Medicine, Clinical Medical College of Traditional Chinese
Medicine, China Three Gorges University. The participants
are informed of the potential benefits, risks, alternatives,
and responsibilities during the study before they are asked
to provide consent. Potential mild adverse events, reported
to be related to electro-acupuncture treatment, are pain,
bleeding, tiredness, and a feeling of faintness in the acu-
puncture group [23], and skin redness and pressure marks
in the other groups, but these mild symptoms will generally
resolve spontaneously after treatment. Additionally, ABVN
is thought to be involved in some peculiar somatovisceral
reflexes. For instance, an ear-cough reflex (Arnold’s reflex)
is estimated to be present in approximately 4% [24] of the
general population, while there is rare occurrence of ear-
gag reflex, ear-lacrimal reflex and auricular syncope
[24,25]. So there is a rare possibility that patients in the
two groups receiving ABVN stimulation might have these
reflexes. Participants who show any adverse effects during
the course of the therapy will receive appropriate treat-
ment immediately. All adverse effects will be documented,
and patients with persistent worsening symptoms will be
withdrawn from the study.
Discussion
We have presented the design and protocol for the ran-
domized controlled clinical study for tinnitus patients. If
it proves successful, this new treatment method could
offer hope to millions of patients who are affected by
tinnitus.
Although the exact pathophysiology of tinnitus still
remains elusive, it is believed that an abnormal bal-
ance between inhibition and excitation causing map
reorganization of central auditory circuits underlies
many forms of tinnitus [26]. Moreover, signs of abnor-
mal activity were not only revealed in the central audi-
tory system but also in non-auditory areas, including
the limbic system [27-29]. The annoyance of tinnitus
is not correlated with its acoustic characteristics, but
there is a significant correlation with psychological
symptoms [30]. The autonomic nervous system is a
major factor in the difference between simply perceiv-
ing tinnitus and being distressed by it [31]. Studies
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tively with sympathetic markers and negatively with
parasympathetic markers [32,33]. Accumulating evi-
dence illustrates that tinnitus is correlated with symp-
toms of distress, such as emotional stress and
depression for the important role of the limbic system
in the pathophysiology of tinnitus, which is based on
the further understanding of auditory-limbic interac-
tions [34-36].
Vagal nerve stimulation was developed based on this
growing understanding of tinnitus. It may work by acti-
vating the nucleus of the solitary tract, which, in turn,
may activate the locus coeruleus and nucleus basalis,
which release neuromodulators that have significant ef-
fects on learning and memory and in plasticity regula-
tion by modulating neurons in the cortex, hippocampus,
and amygdala [26]. Engineer and colleagues [8] have in-
dicated that cervical VNS paired with specific auditory
stimuli completely eliminated the physiological and
behavioral correlates of the phantom sound. They ob-
served that pairing tones with VNS significantly acutely
increased excitability and suppressed spontaneous
multi-unit activity in rat auditory cortex [37]. Indeed,
beneficial effects in relieving psychological symptoms
have been confirmed in patients with tinnitus using in-
vasive VNS pairing tones [21] or transcutaneous VNS
paired with tones [19,38] in recent small sample pilot
studies. However, another experiment also demonstrated
that VNS-directed long-lasting reversal of pathological
neural plasticity is driven by the repeated association of
VNS with tones, and not by VNS alone [8]. German
researchers [14] claimed that no clinically relevant
improvement of tinnitus complaints was observed after
transcutaneous VNS alone. To some extent, this may
confirm the suggestion that stimulation at ABVN might
prove less effective than VNS because fibers from the
auricular branch do not primarily target the nucleus of
the solitary tract and so only target it partly. Otherwise,
as these researchers themselves suggested [14], the most
probable explanation is that VNS alone is not effective
in reducing tinnitus, which is supported by the work of
Engineer et al. [8]. While sound stimulus alone, as a
common sensory exposure treatment strategy, has been
applied to treat tinnitus for many years [39,40], studies
have indicated that it has only provided some temporary
relief [41,42]. Therefore, to identify whether ABVN or
the combination of ABVN and sound stimulus plays a
more important role in relieving tinnitus, we designed
this four-armed novel trial to determine their specific
effect on tinnitus.
Acupuncture is an important part of traditional
Chinese medicine. It has been accepted in China for
thousands of years and is now used as an alternative and
complementary medical therapy in Western countries.Meta-analysis results have indicated that acupuncture or
acupuncture combined with other therapies is superior
to medication alone or non-acupuncture treatments in
treating subjective tinnitus [43]. However, in another
systematic review, acupuncture for the treatment of tin-
nitus has not been demonstrated to be efficacious [44].
Whether acupuncture is effective or not in the treatment
of tinnitus is a question worthy of discussion. According
to the theory of traditional Chinese medicine, the shao-
yang meridians of the hand and foot travel to the ear re-
gion, so acupoints of the shaoyang meridians located
both in local and distant areas of the ear are used to treat
tinnitus in this protocol. In addition, the specific acupoints
Yifeng (TE17), Tinghui (GB2), Xiaxi (GB43), and Zhongzhu
(TE3) are usually chosen in treating tinnitus.
Auricular acupuncture, as an important branch of acu-
puncture, has also been utilized in the treatment of dis-
eases for years. In ancient China’s earliest medical text
Huang Di Nei Jing, which was compiled in the 5th cen-
tury BC, the correlation between the external ear and
the body or viscera is described. In 1957, Dr. Paul
Nogier, a physician in France, first originated the con-
cept of an inverted fetus map on the external ear [45].
He proposed a theory that there is a somatotopic and
viscerotopic representation on the auricle [46]. Accord-
ing to these theories, disorders from a particular part of
the body or viscera can be treated by the corresponding
points in the ear [46,47]. Therefore, related auricular
acupoints such as Kidney (CO10), Yidan (CO11), or
Liver (CO12) are usually selected to treat tinnitus,
which, according to the organ-viscera theory of trad-
itional Chinese medicine, results from insufficient
Kidney qi or dampness-heat of the Liver and Gallbladder.
The Shenmen point (TF4) has the effect of tranquilizing
the mind [48,49]. It is often utilized to remedy mental ill-
nesses or psychiatric disorders, such as insomnia [50], anx-
iety [51,52], or tinnitus [53]. However, the physiological
mechanisms associated with these auricular acupoints re-
main unclear. In this study, it is proposed that the auto-
nomic and the central nervous system could be modified
by auricular vagal stimulation via projection from the
ABVN to the nucleus of the solitary tract [54], which might
work through the neuromodulator system, thus directing
plasticity to treat tinnitus.
However, our study has several potential limitations.
First, all the outcome measures are self-assessments in-
stead of objective measures. To some extent, objective
measures carry out relatively convincing evidence. How-
ever, the Tinnitus Handicap Inventory [55,56], visual
analogue scale [56], and Hospital Anxiety and Depres-
sion Scale [57] have been much used in most of the
randomized controlled trials on tinnitus and they are
proved to be efficient in reflecting the subjective emo-
tional changes related to tinnitus. Second, this trial is
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pists might bias the outcome assessments. However, it is
hard to blind the therapists, who are required to be
familiar with treatments for the specific grouping assign-
ment. Another limitation concerns the fact that this is a
single center study. It does not lend results to great
generalizability to more diverse sets of patients in more
diverse regions. In addition, the sample size in this study
is relatively small. A large sample, multicenter, and ob-
jective measures to assess the effectiveness of treatment
should be included in a future study.
Trial status
This trial is currently recruiting participants.
Consent
Written informed consent was obtained from the partici-
pants for publication of this manuscript and accompanying
images. A copy of the written consent is available for review
by the editor-in-chief of this journal.
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